Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
MCF7
HR+
Luminal
Ixabepilone
TUBB
TUBB
7492.095
uM
inf
inf
0.9180 0.9180 0.0000 0.0139
0.0229
1.0194
HCC1395
TNBC
Basal B
AG1024
IGF1R
RTK
7435.066
uM
inf
inf
0.8858 0.8858 0.0000 0.0656
-0.0232
0.8924
SK-BR-3
HER2amp
Luminal
Cetuximab
EGFR
ErbB
10127.123
uM
inf
inf
0.7010 0.7010 0.0000 0.1340
0.0237
0.8767
MDA-MB-361
HER2amp
Luminal
Nilotinib
ABL
nRTK
12379.17
uM
inf
inf
0.9413 0.9413 0.0000 -0.0239
-0.0238
0.5805
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7473.091
uM
inf
inf
0.9017 0.9017 0.0000 -0.0408
-0.0238
2.3297
BT-483
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
11855.135
uM
inf
inf
0.6973 0.6973 0.0000 0.1313
-0.0247
0.6394
HCC38
TNBC
Basal B
Ribavirin
15351.211
uM
inf
inf
0.7443 0.7443 0.0000 0.0613
-0.0247
1.0866
AU565
HER2amp
Luminal
Nilotinib
ABL
nRTK
10880.145
uM
inf
inf
0.9804 0.9804 0.0000 0.0621
0.0247
1.4751
HCC1569
HER2amp
Basal A
Methotrexate
DHFR
Metabolism
7449.084
uM
inf
inf
0.9327 0.9327 0.0000 0.0427
0.0247
2.1410
HCC38
TNBC
Basal B
TCS PIM-1 1
Pim kinase
PIM
10578.135
uM
inf
inf
0.9081 0.9081 0.0000 0.0395
0.0248
1.7650
HCC3153
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7465.095
uM
inf
inf
0.8393 0.8393 0.0000 0.1223
-0.0252
1.2754
HCC1187
TNBC
Basal A
AG1478
EGFR
ErbB
7811.044
uM
inf
inf
0.9811 0.9811 0.0000 0.0159
-0.0256
0.3073
CAMA-1
HR+
Luminal
PD 98059
MEK
MAPK
10755.152
uM
inf
inf
0.5641 0.5641 0.0000 0.2866
-0.0260
0.5859
SUM229PE
TNBC
-
Disulfiram
Proteasome
Proteasome
13062.174
uM
inf
inf
0.9527 0.9527 0.0000 0.0333
0.0263
1.6688
UACC-893
HER2amp
Luminal
Cisplatin
DNA cross-linker
DNA cross-linker
9953.049
uM
inf
inf
1.0500 1.0500 0.0000 0.0816
0.0269
0.5411
HCC2185
TNBC
Luminal
FTase Inhibitor I
Ftase
MAPK
12192.154
uM
inf
inf
0.9309 0.9309 0.0000 -0.0048
-0.0270
0.5377
HCC1937
TNBC
Basal A
Cetuximab
EGFR
ErbB
7833.042
uM
inf
inf
0.8856 0.8856 0.0000 0.0972
0.0274
1.0332
MDA-MB-361
HER2amp
Luminal
Nelfinavir
13558.174
uM
inf
inf
0.7427 0.7427 0.0000 0.1261
0.0278
0.5699
HCC1954
HER2amp
Basal A
Cetuximab
EGFR
ErbB
7837.042
uM
inf
inf
0.5276 0.5276 0.0000 0.1898
-0.0281
1.6916
MDA-MB-361
HER2amp
Luminal
GM6001
MMP
MMP
7506.096
uM
inf
inf
0.9793 0.9793 0.0000 0.0173
-0.0292
1.0303
MDA-MB-453
TNBC
Luminal
PS-1145
IKK
NFKB
7515.065
uM
inf
inf
0.7626 0.7626 0.0000 0.1588
0.0295
1.3234
MDA-MB-415
HR+
Luminal
Lapatinib
EGFR/HER2
ErbB
7510.098
uM
inf
inf
0.9619 0.9619 0.0000 0.0329
-0.0298
0.9528
CAMA-1
HR+
Luminal
Nilotinib
ABL
nRTK
12070.145
uM
inf
inf
0.8990 0.8990 0.0000 0.1345
0.0301
1.0737
MDA-MB-157
TNBC
Basal B
Dichloroacetate
PDK
PDK
12632.176
uM
inf
inf
0.8532 0.8532 0.0000 0.0329
0.0301
0.8098
CAMA-1
HR+
Luminal
Purvalanol A
CDK1
CDK
5912.067
uM
inf
inf
0.8672 0.8672 0.0000 0.0876
-0.0304
1.1725